Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanisms for Glucagon Resistance as Driver of Metabolic Associated Steatotic Liver Disease and Cardiovascular Disease in Humans With Type 2 Diabetes

NCT07246421 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT07246421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07246421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanisms for Glucagon Resistance as Driver of Metabolic Associated Steatotic Liver Disease and Cardiovascular Disease in Humans With Type 2 Diabetes
Lead sponsor
University of Aarhus
Phase
Not applicable
Overall status
Recruiting
Start date
January 29, 2026
Completion date
July 31, 2028
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic associated fatty liver disease, type 2 diabetes (t2dm)